Tested Applications
| Positive WB detected in | A549 cells, HeLa cells, MDA-MB-453s cells, NIH/3T3 cells |
| Positive IHC detected in | human ovary tumor tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
| Positive IF/ICC detected in | HeLa cells, HepG2 cells |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:1000-1:6000 |
| Immunohistochemistry (IHC) | IHC : 1:50-1:500 |
| Immunofluorescence (IF)/ICC | IF/ICC : 1:50-1:500 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
26613-1-AP targets BRM/SMARCA2-Specific in WB, IHC, IF/ICC, CoIP, ELISA applications and shows reactivity with human, mouse samples.
| Tested Reactivity | human, mouse |
| Cited Reactivity | human, mouse, rat |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag25157 Product name: Recombinant human SMARCA2-Specific protein Source: e coli.-derived, PET30a Tag: 6*His Domain: 1-272 aa of NM_003070 Sequence: MSTPTDPGAMPHPGPSPGPGPSPGPILGPSPGPGPSPGSVHSMMGPSPGPPSVSHPMPTMGSTDFPQEGMHQMHKPIDGIHDKGIVEDIHCGSMKGTGMRPPHPGMGPPQSPMDQHSQGYMSPHPSPLGAPEHVSSPMSGGGPTPPQMPPSQPGALIPGDPQAMSQPNRGPSPFSPVQLHQLRAQILAYKMLARGQPLPETLQLAVQGKRTLPGLQQQQQQQQQQQQQQQQQQQQQQQPQQQPPQPQTQQQQQPALVNYNRPSGPGPELSGP Predict reactive species |
| Full Name | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 |
| Calculated Molecular Weight | 181 kDa |
| Observed Molecular Weight | 180-190 kDa |
| GenBank Accession Number | NM_003070 |
| Gene Symbol | SMARCA2 |
| Gene ID (NCBI) | 6595 |
| RRID | AB_2880575 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | P51531 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
SMARCA2 is a transcriptional coactivator cooperating with nuclear hormone receptors to potentiate transcriptional activation. SMARCA2 is involved in vitamin D-coupled transcription regulation via its association with the WINAC complex, a chromatin-remodeling complex recruited by vitamin D receptor (VDR), which is required for the ligand-bound VDR-mediated transrepression of the CYP27B1 gene.
Protocols
| Product Specific Protocols | |
|---|---|
| IF protocol for BRM/SMARCA2-Specific antibody 26613-1-AP | Download protocol |
| IHC protocol for BRM/SMARCA2-Specific antibody 26613-1-AP | Download protocol |
| WB protocol for BRM/SMARCA2-Specific antibody 26613-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The BRM/SMARCA2-Specific Polyclonal antibody (Cat# 26613-1-AP) has 8 total citations. These appear in journals including Nature Communications, Neuron, Nature Structural & Molecular Biology, Cell Reports, Stem Cells, Journal of Cellular and Molecular Medicine, Biochemical and Biophysical Research Communications, and Oncology Letters. The associated research fields span cancer biology (Ewing's sarcoma, glioma, ovarian cancer), chromatin remodeling and SWI/SNF complex function, phase separation, PROTAC design, oligodendrocyte differentiation, and mTOR gene transcription.
| Species | Application | Title |
|---|---|---|
Nat Commun Prion-like domain mediated phase separation of ARID1A promotes oncogenic potential of Ewing's sarcoma | ||
Neuron Nucleoporin Seh1 Interacts with Olig2/Brd7 to Promote Oligodendrocyte Differentiation and Myelination. | ||
Nat Struct Mol Biol Design of PROTACs utilizing the E3 ligase GID4 for targeted protein degradation | ||
Cell Rep SWI/SNF complex-mediated ZNF410 cooperative binding maintains chromatin accessibility and enhancer activity | ||
Stem Cells Chromatin Remodeling Factor BRG1 Regulates Stemness and Chemosensitivity of Glioma Initiating Cells. | ||
J Cell Mol Med Tyr1497 in the BRG1 Bromodomain of the SWI/SNF Complex is Critical for the Binding and Function of a Selective BRG1 Inhibitor |



















